Natural Product: NPC519289

Natural Product IDNPC519289
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
5,6-dihydroxy-7-[(2~{S},3~{R},4~{S},5~{R},6~{R})-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-[4-[(2~{S},3~{S},4~{R},5~{R},6~{S})-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxyphenyl]chromen-4-one
IUPAC Name 5,6-dihydroxy-7-[(2~{S},3~{R},4~{S},5~{R},6~{R})-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-[4-[(2~{S},3~{S},4~{R},5~{R},6~{S})-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxyphenyl]chromen-4-one
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey PATAJOYWUAAQGX-JUSLCMBCSA-N
Standard InCHI InChI=1S/C27H30O14/c1-9-18(29)22(33)24(35)26(37-9)39-12-5-3-11(4-6-12)14-7-13(28)17-15(40-14)8-16(20(31)21(17)32)41-27-25(36)23(34)19(30)10(2)38-27/h3-10,18-19,22-27,29-36H,1-2H3/t9-,10+,18-,19-,22+,23-,24-,25+,26-,27-/m0/s1
SMILES C[C@@H]1O[C@@H](OC2=CC=C(C3=CC(=O)C4=C(O)C(O)=C(O[C@@H]5O[C@H](C)[C@H](O)[C@H](O)[C@H]5O)C=C4O3)C=C2)[C@@H](O)[C@H](O)[C@H]1O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   578.16 Volume:   534.737
?
Van der Waals volume.
Dense:   1.081 LogP:   1.462
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.763
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.6
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   5.0 Rigid Bonds:   30.0
TPSA:   228.97
?
Topological Polar Surface Area.
H-Bond Acceptor:   14.0
H-Bond Donor:   8.0 Rings:   5.0
Heavy Atoms:   14.0

MedChem Properties

QED Drug-Likeness Score:   0.175 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.662 Fsp3:   0.444
MCE-18:   119.436
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   1 PAINS Alert:   1
Colloidal aggregators:   0.632 Fluc inhibitor:   0.332
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.89
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.699
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.241 Promiscuous compounds:   0.43

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.338 MDCK Permeability:   -5.18
Pgp-inhibitor:   0.0 Pgp-substrate:   0.798
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.61
20% Bioavailability (F20%):   0.51 30% Bioavailability (F30%):   0.954
50% Bioavailability (F50%):   0.994

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.463
Plasma Protein Binding (PPB):   85.695% Volume Distribution (VD):   -0.032
Fu: 11.779%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.996
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.494
BSEP inhibitor:   0.006

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.775
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.969
HLM stability:   0.03
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  1.773 Half-life (T1/2):  5.714

ADMET: Toxicity

hERG Blockers:  0.034 hERG Blockers (10um):  0.227
Human Hepatotoxicity (H-HT):  0.489 Drug-induced Liver Injury (DILI):  0.985
AMES Toxicity:  0.962 Rat Oral Acute Toxicity:  0.03
Maximum Recommended Daily Dose:  0.044 Skin Sensitization:  0.987
Carcinogencity:  0.06 Eye Corrosion:  0.0
Eye Irritation:  0.122 Respiratory Toxicity:  0.023
Drug-induced Neurotoxicity:  0.003 Ototoxicity:  0.968
Hematotoxicity:  0.276 Drug-induced Nephrotoxicity:  0.777
Genotoxicity:  0.903 RPMI-8226 Immunitoxicity:  0.216
A549 Cytotoxicity:  0.588 Hek293 Cytotoxicity:  0.418
BCF:   0.384
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.081
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.627
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.808
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO50863 Atraphaxis pyrifolia Species Polygonaceae Eukaryota n.a. n.a. n.a. PMID[38398586]
NPO50863 Atraphaxis pyrifolia Species Polygonaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC519289 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7297 Intermediate Similarity NPC45618
0.72 Intermediate Similarity NPC146792
0.6883 Remote Similarity NPC58716
0.6711 Remote Similarity NPC331652
0.641 Remote Similarity NPC58053
0.641 Remote Similarity NPC19709
0.6282 Remote Similarity NPC473043
0.625 Remote Similarity NPC186807
0.6207 Remote Similarity NPC204693
0.6176 Remote Similarity NPC57030
0.6125 Remote Similarity NPC95090
0.6125 Remote Similarity NPC27408
0.6092 Remote Similarity NPC22062
0.6092 Remote Similarity NPC473634
0.6092 Remote Similarity NPC138811
0.6049 Remote Similarity NPC181712
0.6 Remote Similarity NPC211594
0.6 Remote Similarity NPC143851
0.5904 Remote Similarity NPC237435
0.5833 Remote Similarity NPC43211
0.5833 Remote Similarity NPC605067
0.573 Remote Similarity NPC3583
0.5652 Remote Similarity NPC209296
0.5647 Remote Similarity NPC22832
0.5618 Remote Similarity NPC44931
0.561 Remote Similarity NPC39360
0.561 Remote Similarity NPC29763
0.561 Remote Similarity NPC210003
0.5595 Remote Similarity NPC27942
0.5532 Remote Similarity NPC475382
0.5529 Remote Similarity NPC609451
0.5529 Remote Similarity NPC611303
0.5488 Remote Similarity NPC160515
0.5476 Remote Similarity NPC245014
0.5476 Remote Similarity NPC84265
0.5476 Remote Similarity NPC105025
0.5465 Remote Similarity NPC243930
0.5465 Remote Similarity NPC601144
0.5455 Remote Similarity NPC477848
0.5422 Remote Similarity NPC261866
0.5402 Remote Similarity NPC607707
0.5393 Remote Similarity NPC251417
0.5385 Remote Similarity NPC210073
0.5357 Remote Similarity NPC93337
0.5357 Remote Similarity NPC189142
0.5357 Remote Similarity NPC77660
0.5352 Remote Similarity NPC275722
0.5349 Remote Similarity NPC191306
0.5342 Remote Similarity NPC212678
0.5341 Remote Similarity NPC190003
0.5333 Remote Similarity NPC603300
0.5326 Remote Similarity NPC257566
0.5319 Remote Similarity NPC473623
0.5319 Remote Similarity NPC483707
0.5287 Remote Similarity NPC115760
0.5287 Remote Similarity NPC181616
0.5287 Remote Similarity NPC606560
0.5281 Remote Similarity NPC172807
0.5278 Remote Similarity NPC198826
0.527 Remote Similarity NPC283600
0.5269 Remote Similarity NPC46202
0.5263 Remote Similarity NPC485299
0.5263 Remote Similarity NPC488089
0.5238 Remote Similarity NPC249281
0.5238 Remote Similarity NPC108831
0.5238 Remote Similarity NPC238376
0.5238 Remote Similarity NPC182634
0.5233 Remote Similarity NPC201292
0.5227 Remote Similarity NPC311830
0.5227 Remote Similarity NPC602805
0.5217 Remote Similarity NPC65003
0.5155 Remote Similarity NPC298171
0.5152 Remote Similarity NPC11468
0.5122 Remote Similarity NPC25547
0.5116 Remote Similarity NPC46420
0.5116 Remote Similarity NPC271692
0.5116 Remote Similarity NPC27640
0.5116 Remote Similarity NPC45638
0.5068 Remote Similarity NPC145379
0.5059 Remote Similarity NPC289667
0.5055 Remote Similarity NPC254540
0.5053 Remote Similarity NPC470443

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC519289 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5904 Remote Similarity NPD4338 Clinical (unspecified phase)
0.5652 Remote Similarity NPD7054 Phase 4

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data